Efficacy of intravenous granisetron in suppressing the bradycardia and hypotension associated with a rabbit model of the Bezold-Jarisch reflex

Journal of Clinical Pharmacology

Volumn 38, Issue 2, 1998, Pages 172-177

  White, C Michael ^a,b   Chow, Moses S S ^a,b   Fan, Chengde ^b   Kluger, Jeffrey ^b   Bazunga, Munama ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANISETRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BRADYCARDIA; CONTROLLED STUDY; DRUG EFFICACY; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RABBIT; SYNCOPE; SYSTOLIC BLOOD PRESSURE;

EID: 0031883602     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04407.x     Document Type: Article

References (25)

1. Schadt JC, Ludbrook J: Hemodynamic and neurohormonal responses to acute hypovolemia in conscious mammals. Am J Physiol 1991;260:H305-H318.
2. Morita H, Vatner SF: Effects of hemorrhage on renal nerve activity in conscious dogs. Circ Res 1985;57:788-793.
3. Schadt JC, McKnown MD, McKnown DP, Franklin D: Hemodynamic effects of hemorrhage and subsequent naloxone treatment in conscious rabbits. Am J Physiol 1984;247:R497-R508.
4. Skoog P, Mansson J, Thoren P: Changes in renal sympathetic outflow during hypotensive haemorrhage in rats. Acta Physiol Scand 1985;125:655-660.
5. Kosinski D, Grubb BP, Temesy-Armos P: Pathophysiological aspects of neurocardiogenic syncope: current concepts and new perspectives. Pacing Clin Electrophysiol 1995;18:716-724.
6. Hammill SC, Thomas JE: Syncopal disorders. In, Giulliani ER, Gersh BJ, McGoon MD, Haves DL, Schaff HV (eds.): Mayo Clinic Practice of Cardiology. Third edition. St. Louis, MO: CV Mosby, 1996;849-861.
7. Lazarus JC, Mauro VF: Syncope: pathophysiology, diagnosis, and pharmacotherapy. Ann Pharmacother 1996;30:994-1005.
8. Shalev Y, Gal R, Thou P, Anderson AJ, Avitall B, Akhtar M, Jazayeri MR: Echocardiographic demonstration of decreased left-ventricular dimensions and vigorous myocardial contraction during syncope induced by head-upright tilt. J Am Coll Cardiol 1991;18:748-751.
9. Kalkman HO, Engel G, Hoyer D: Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats. J Hypertens 1984;2(suppl 3):143-145.
10. Grubb BP, Kosinski D: Tilt table testing: concepts and limitations. Pacing Clin Electrophysiol 1997;20:781-787.
11. Chen MY, Goldenberg IF, Milstein S, Buchkofer J, Almquist A, Lesser J, Benditt DG: Cardiac electrophysiology and hemodynamic correlation of neurally mediated syncope. Am J Cardiol 1989;63:66-72.
12. Thoren PN: Activation of the left-ventricular receptors with non-medullated vagal afferent fibers during occlusion of a coronary artery in the cat. Am J Cardiol 1976;37:1046-1051.
13. Schadt JC, Lubbrook J: Hemodynamic and neurohormonal responses to acute hypovolemia in conscious mammals. Am J Physiol 1991;260(suppl 29):H305-H318.
14. Quan KJ, Carlson MD, Thames MD: Mechanisms of heart rate and arterial blood pressure control: implications for the pathophysiology of neurocardiogenic syncope. Pacing Clin Electrophysiol 1997;20:764-774.
15. Eglen RM, Lee CH, Khabbaz M, Fontana DJ, Kilfoil T, Wong EH: Comparison of potencies of 5-HT3 receptor antagonists at inhibiting aversion behavior to illumination and the von Bezold-Jarisch reflex in the mouse. Neuropharmacology 1994;33:227-234.
16. Moran A, Velasco C, Martin ML, San Roman L: Pharmacological characterization of 5-HT receptors in parasympathetic innervation of the rat heart. Eur J Pharmacol 1994;252:161-166.
17. Adams VR, Valley AW: Granisetron: the second serotonin-receptor antagonist. Ann Pharmacother 1995;29:1240-1251.
18. Kapoor W, Karpf M, Wieand S, Peterson JR, Levey GS: A prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983;309:197-204.
19. Kligfield P: Tilt table for the investigation of syncope: there nothing simple about fainting. J Am Coll Cardiol 1991;17:131-132.
20. Abi-Samra F, Maloney J: The usefulness of head-up tilt testing and hemodynamic investigations in the work-up of syncope of unknow origin (abstract). Pacing Clin Electrophysiol 1987;10:406.
21. Yarker YE, McTavish D: Granisetron: an update of its therapeutic use in nausea and vomiting induced by antmeoplastic therapy. Drugs 1994;48:761-793.
22. Kamanabrou D: Intravenous granisetron: establishing the optimal dose. Eur J Cancer 1992;28A(suppl 1):S6-S11.
23. Wet MD, Falkson G, Rapport BL: Repeated use of granisetron in patients receiving cytostatic agents. Cancer 1993;71:4043-4049.
24. McEvoy GK, Litvak K (eds.): Drug Information. Bethesda, MD: American Society of Health-Systems Pharmacists, 1997
25. Sproat TT, Lopez LM: Around the beta-blockers, one more time. Ann Pharmacother 1991;25:962-971.